FDA issues recall of unregistered grand chateaux sangria forte over safety concerns
- Think News Online
- Mar 20
- 2 min read

The Food and Drugs Authority (FDA) has issued a product recall for Grand Chateaux Sangria Forte in both Tetra Pak (250ml) and Canned (330ml Pétillante) packaging.
The recall follows the discovery that these products are unregistered and are being illegally sold and advertised on the Ghanaian market and social media platforms.
In a statement signed by the Chief Executive Officer of the FDA, Dr. Delese A. A. Mimi Darko, the Authority highlighted that the importer of these products has violated Sections 97, 98, and 103 of the Public Health Act, 2012 (Act 851) by failing to secure the necessary registration for the sale and distribution of the products.
Reasons for Recall
The FDA outlined the following reasons for the recall:
1. The products are not registered with the FDA, making their sale and distribution illegal.
2. The packaging and size of the products are considered deceptive and misleading, posing a potential risk of accidental alcohol ingestion by children, thereby endangering their health and safety.
The FDA has directed the following actions to ensure public safety:
Consumers are advised to refrain from purchasing or consuming the affected products.
Retailers and wholesalers are instructed to immediately stop the sale and distribution of Grand Chateaux Sangria Forte.
The importer of the products has been sanctioned, and the FDA has initiated regulatory measures to prevent further violations.
Consumers who have already purchased the product are encouraged to return them to the point of sale or any FDA office nationwide.
The FDA reassured the public of its commitment to protecting consumer health and safety through strict enforcement of health regulations.
The Authority also urged consumers to remain vigilant and report any suspicious or unregistered products to its offices for prompt action.
Dr. Darko emphasized that the FDA will continue to monitor the market to prevent the sale of unregistered and potentially harmful products.
Story by: Joshua Kwabena Smith
Comments